ProsKit 900-038 Hex Key Set - US and Metric Tools & Home Improvement

Tools & Home Improvement
Power & Hand Tools
Hand Tools
Wrenches
Hex Keys
ProsKit 900-038 Hex Key Set - US and Metric Tools & Home Improvement

ProsKit 900-038 Hex Key Set - US and Metric Tools & Home Improvement

ProsKit 900-038 Hex Key Set - US and MetricTools & Home Improvement Power & Hand Tools Hand Tools Wrenches Hex Keys ProsKit 900-038 Hex Key Set - US and Metric Tools & Home Improvement

ProsKit 900-038 Hex Key Set - US and Metric Tools & Home Improvement

Jian E Safety Mirror Outdoor Traffic Wide-angle Lens Road Wide-angle Lens Convex Spherical Mirror Corner Curved Mirror Concave Mirror Anti-theft Mirror // Color Outdoor Size 45cm in diameter LINGJIA Bicycle Saddle Bicycle Saddle Brown Big Ass Road Bike Cycling Seat for Men Women Tour Bikes Saddle Accessories Parts Weginte Women T Shirts Casual Summer 3/14 Bell Sleeve Plain Printed Loose Plus Size Shirts Tops Tees Blouses T-Shirt CLOB Projector Remote Control for EPSON Projector H370C. Glidden Interior Paint Primer Purple/Victorian Plum One Coat Eggshell 1-Gallon Danyel Beauty Salon Chair Barber Chair Heavy Duty Hydraulic Beauty Styling Salon ChairBlack Oil SeaL Size-1.500inchX2.332inchX0.375inch Pack of 5 FB Jewels Solid 925 Sterling Silver Tie Bar Stamping Eagle KEG804 Deluxe Counter Pressure Bottle Filler Silver

Accelerating Cancer Research

Placing the patient at the center of cancer care

JOIN US

BREAKING THROUGH TO FUNDING CANCER RESEARCH CLINICAL TRIALS

Gateway for Cancer Research accelerates practice-changing clinical trials to cancer research by harnessing the unrelenting passion of the research community and empowering patients to triumph over their disease. All of this is guided by a clear vision: To shape a world in which a cancer diagnosis is no longer feared.

For Researchers

Explore Gateway’s cutting-edge cancer research program

Model of Support

Explore Grant Opportunities

Apply for a Grant

Gateway Impact

Learn more about Gateway for Cancer Research and our critical mission

Our Story

Why Give to Gateway

Explore Clinical Trials

For Supporters

Donate to cancer research today and help advance lifesaving cancer research

Patient Story

Donate Today

Fundraise for Gateway

Our most prestigious giving level, Gateway Concierge is a dynamic ecosystem that allows forward-thinking philanthropists to co-create new possibilities in cancer care. Gateway will connect global benefactors with world-class clinician-scientists to create a research program that will deliver results in the fight against cancer—enabling real human impact now.

Get Started

GATEWAY FOR CANCER RESEARCH STORIES

Read about the unwavering patients and the cancer researchers who are helping us put and end to cancer as we know it.

Patient Profile: Kent

Kent enrolled in a Gateway-funded cancer research trial to treat his acute myeloid leukemia. See what he and his doctor had to say about his experience in this trial.

Watch Kent’s Story

Gateway’s Impact

9,000+ patients have been impacted by Gateway for Cancer Research funded clinical trials to date.

ASCO Connection

Improving Health Equity Together: A Conversation with Maria Rubinstein, Sameek Roychowdhury, and Mary Lou Smith

Read the Article

“Never again am I going to look at a birthday and say, ‘I can’t believe I’m going to be another year older.’ Now I’m saying, ‘I’m so glad to be another year older!’”

- Beth, lymphoma patient in a Gateway-funded trial

Why Give to Gateway

99 cents of every dollar donated to Gateway goes directly towards funding a cancer clinical trial.

DONATE NOW

EORTC

Gateway Supports European Organisation for Research and Treatment of Cancer Grant

Did You Know?

190+ clinical trials have been funded worldwide by Gateway for Cancer Research since 1991.

View Our Clinical Trials

LATEST CANCER RESEARCH

Gateway for Cancer Research only invests in Phase I and Phase II human clinical trials where true innovation and transformational discoveries happen.

Trial Type: Lung Cancer

Identification of Predictive Biomarkers to Prevent Pneumonitis in Patients with Non-Small Cell Lung Cancer Who are Receiving Immunotherapy (Phase II)

Ajay Sheshadri, MD
The University of Texas MD Anderson Cancer Center

Trial Type: Pancreatic Cancer

Novel Use of Pepinemab in Combination with Nivolumab and FOLFIRINOX Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma (Phase Ib/II)

David Linehan, MD
University of Rochester

VIEW ALL TRIALS

APPLY FOR A GRANT

Extraordinary Times Call for Extraordinary Measures

COVID-19 significantly disrupted patient access to clinical trials—research that can make a world of difference for those facing cancer. In response to this long-term trend, Gateway launched an innovative new funding program to support “decentralized” clinical studies that bring trials to the doorsteps of cancer patients by leveraging technology and at-home care.

Extraordinary Measures, an urgent new fundraising campaign unlike any we have ever conducted in our nearly 30-year history, will advance this new grant program, helping to ensure all those facing cancer continue to receive potentially lifesaving therapies.

Fund One Day

It costs just $16.56 per patient per day in a Gateway-funded cancer clinical trial.

Help us fund another day of research, another week or more. You can even mark your gift with a special date, such as an anniverary, birthday, wedding, bar/bat mitzvah or graduation.

ProsKit 900-038 Hex Key Set - US and Metric Tools & Home Improvement

ProsKit 900-038 Hex Key Set - US and Metric Tools & Home Improvement

ProsKit 900-038 Hex Key Set - US and Metric Tools & Home Improvement

Accelerating Cancer Research

BREAKING THROUGH TO FUNDING CANCER RESEARCH CLINICAL TRIALS

For Researchers

Gateway Impact

For Supporters

GATEWAY FOR CANCER RESEARCH STORIES

Patient Profile: Kent

Gateway’s Impact

ASCO Connection

“Never again am I going to look at a birthday and say, ‘I can’t believe I’m going to be another year older.’ Now I’m saying, ‘I’m so glad to be another year older!’”

Why Give to Gateway

EORTC

Did You Know?

LATEST CANCER RESEARCH

Identification of Predictive Biomarkers to Prevent Pneumonitis in Patients with Non-Small Cell Lung Cancer Who are Receiving Immunotherapy (Phase II)

Novel Use of Pepinemab in Combination with Nivolumab and FOLFIRINOX Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma (Phase Ib/II)

Extraordinary Times Call for Extraordinary Measures

Fund One Day

Stay Connected with Gateway